Post by
MrMugsy on Oct 04, 2023 7:54am
October is a busy month ...
Good or Bad ... October is a busy month.
It would be nice if we can get a positive ruling - followed by the start of PK/PD and then followed by a new molecule introduction.
That would pretty much get us where we'd like to be as PK/PD comes to an end and sets us up for P2.
------------------
Predicting the market's move never works so I'll just let Mother Nature deal with that.
Development progress is what I care about ...
1. pills are done and quality checked - that means the process is ready.
2. secondary location for pill manufacture being considered.
3. new formula means faster onset (and faster offset?) - looking for better control in regimen design (opening the door to chronic - round 2 ???)
4. reduced dosing - how low can we actually go? I don't really care about that for acute as it's in the body for such a short duration ... but I'd like to know what it means for chronic and chronic regimen design.
-----------------
This October is a little different - but still scary like a good halloween horror movie. Hahaha !